| |
Clinical drug development depends on the integration of multiple parties – people who become stakeholders in a drug development program. A sponsor that outsources a drug development project must be confident that the CRO chosen can integrate investigators, coordinators, clinical monitors, medical monitors, clinical laboratories, and a host of other individuals and organizations effectively and efficiently. That is especially true in early phase studies, when new project teams form, and it is one reason that Clinilabs has been chosen as a vendor by eight of the world’s top 20 pharma companies. We are experts in building functional teams and maximizing operational performance.
|